Candel Therapeutics (CADL) Other Non-Current Assets (2020 - 2023)
Historic Other Non-Current Assets for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $300000.0.
- Candel Therapeutics' Other Non-Current Assets rose 1278.2% to $300000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $300000.0, marking a year-over-year increase of 1278.2%. This contributed to the annual value of $300000.0 for FY2022, which is 2924.53% down from last year.
- Per Candel Therapeutics' latest filing, its Other Non-Current Assets stood at $300000.0 for Q3 2023, which was up 1278.2% from $300000.0 recorded in Q2 2023.
- In the past 5 years, Candel Therapeutics' Other Non-Current Assets registered a high of $1.7 million during Q2 2021, and its lowest value of $266000.0 during Q2 2022.
- In the last 4 years, Candel Therapeutics' Other Non-Current Assets had a median value of $300000.0 in 2022 and averaged $461545.5.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 2149.0% in 2021, then plummeted by 8446.26% in 2022.
- Quarter analysis of 4 years shows Candel Therapeutics' Other Non-Current Assets stood at $349000.0 in 2020, then increased by 21.49% to $424000.0 in 2021, then decreased by 29.25% to $300000.0 in 2022, then changed by 0.0% to $300000.0 in 2023.
- Its Other Non-Current Assets was $300000.0 in Q3 2023, compared to $300000.0 in Q2 2023 and $300000.0 in Q1 2023.